255 related articles for article (PubMed ID: 28490334)
1. HN1 contributes to migration, invasion, and tumorigenesis of breast cancer by enhancing MYC activity.
Zhang C; Xu B; Lu S; Zhao Y; Liu P
Mol Cancer; 2017 May; 16(1):90. PubMed ID: 28490334
[TBL] [Abstract][Full Text] [Related]
2. TIMELESS contributes to the progression of breast cancer through activation of MYC.
Chi L; Zou Y; Qin L; Ma W; Hao Y; Tang Y; Luo R; Wu Z
Breast Cancer Res; 2017 May; 19(1):53. PubMed ID: 28464854
[TBL] [Abstract][Full Text] [Related]
3. MiR-132 prohibits proliferation, invasion, migration, and metastasis in breast cancer by targeting HN1.
Zhang ZG; Chen WX; Wu YH; Liang HF; Zhang BX
Biochem Biophys Res Commun; 2014 Nov; 454(1):109-14. PubMed ID: 25450365
[TBL] [Abstract][Full Text] [Related]
4. Hematological and neurological expressed 1 (HN1) activates c-Myc signaling by inhibiting ubiquitin-mediated proteasomal degradation of c-Myc in hepatocellular carcinoma.
Feng J; Liu Y; Fang T; Zhu J; Wang G; Li J
Cell Biol Int; 2023 Mar; 47(3):560-572. PubMed ID: 36403281
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitously expressed hematological and neurological expressed 1 downregulates Akt-mediated GSK3β signaling, and its knockdown results in deregulated G2/M transition in prostate cells.
Varisli L; Gonen-Korkmaz C; Debelec-Butuner B; Erbaykent-Tepedelen B; Muhammed HS; Bogurcu N; Saatcioglu F; Korkmaz KS
DNA Cell Biol; 2011 Jun; 30(6):419-29. PubMed ID: 21323578
[TBL] [Abstract][Full Text] [Related]
6. HMGB1 promotes HCC progression partly by downregulating p21 via ERK/c-Myc pathway and upregulating MMP-2.
Chen Y; Lin C; Liu Y; Jiang Y
Tumour Biol; 2016 Apr; 37(4):4399-408. PubMed ID: 26499944
[TBL] [Abstract][Full Text] [Related]
7. MiR-4282 inhibits proliferation, invasion and metastasis of human breast cancer by targeting Myc.
Zhao J; Jiang GQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8763-8771. PubMed ID: 30575917
[TBL] [Abstract][Full Text] [Related]
8. ETV4 transcription factor and MMP13 metalloprotease are interplaying actors of breast tumorigenesis.
Dumortier M; Ladam F; Damour I; Vacher S; Bièche I; Marchand N; de Launoit Y; Tulasne D; Chotteau-Lelièvre A
Breast Cancer Res; 2018 Jul; 20(1):73. PubMed ID: 29996935
[TBL] [Abstract][Full Text] [Related]
9. c-Myc induced the regulation of long non-coding RNA RHPN1-AS1 on breast cancer cell proliferation via inhibiting P53.
Zhu P; Li Y; Li P; Zhang Y; Wang X
Mol Genet Genomics; 2019 Oct; 294(5):1219-1229. PubMed ID: 31089812
[TBL] [Abstract][Full Text] [Related]
10. PIM1 is responsible for IL-6-induced breast cancer cell EMT and stemness via c-myc activation.
Gao X; Liu X; Lu Y; Wang Y; Cao W; Liu X; Hu H; Wang H
Breast Cancer; 2019 Sep; 26(5):663-671. PubMed ID: 30989585
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of PEBP4 suppresses proliferation, migration and invasion of human breast cancer cells.
Wang SC; Zhou F; Zhou ZY; Hu Z; Chang L; Ma MD
Biomed Pharmacother; 2017 Jun; 90():659-664. PubMed ID: 28415045
[TBL] [Abstract][Full Text] [Related]
12. miR-96 promotes cell proliferation, migration and invasion by targeting PTPN9 in breast cancer.
Hong Y; Liang H; Uzair-Ur-Rehman ; Wang Y; Zhang W; Zhou Y; Chen S; Yu M; Cui S; Liu M; Wang N; Ye C; Zhao C; Liu Y; Fan Q; Zhang CY; Sang J; Zen K; Chen X
Sci Rep; 2016 Nov; 6():37421. PubMed ID: 27857177
[TBL] [Abstract][Full Text] [Related]
13. MYC-driven regulation of long non-coding RNA profiles in breast cancer cells.
Tokgun PE; Tokgun O; Kurt S; Tomatir AG; Akca H
Gene; 2019 Sep; 714():143955. PubMed ID: 31326549
[TBL] [Abstract][Full Text] [Related]
14. Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial-mesenchymal transition.
Gao Y; Ma H; Gao C; Lv Y; Chen X; Xu R; Sun M; Liu X; Lu X; Pei X; Li P
J Transl Med; 2018 Feb; 16(1):38. PubMed ID: 29471858
[TBL] [Abstract][Full Text] [Related]
15. Expression of PRL-3 regulates proliferation and invasion of breast cancer cells in vitro.
Radke I; Götte M; Smollich M; Scharle N; Kiesel L; Wülfing P
Arch Gynecol Obstet; 2017 Dec; 296(6):1153-1160. PubMed ID: 28980126
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-9 promotes the proliferation, migration, and invasion of breast cancer cells via down-regulating FOXO1.
Liu DZ; Chang B; Li XD; Zhang QH; Zou YH
Clin Transl Oncol; 2017 Sep; 19(9):1133-1140. PubMed ID: 28397066
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA MYU promotes prostate cancer proliferation by mediating the miR-184/c-Myc axis.
Wang J; Yang X; Li R; Wang L; Gu Y; Zhao Y; Huang KH; Cheng T; Yuan Y; Gao S
Oncol Rep; 2018 Nov; 40(5):2814-2825. PubMed ID: 30132573
[TBL] [Abstract][Full Text] [Related]
18. SNORD89 promotes stemness phenotype of ovarian cancer cells by regulating Notch1-c-Myc pathway.
Zhu W; Niu J; He M; Zhang L; Lv X; Liu F; Jiang L; Zhang J; Yu Z; Zhao L; Bi J; Yan Y; Wei Q; Huo H; Fan Y; Chen Y; Ding J; Wei M
J Transl Med; 2019 Aug; 17(1):259. PubMed ID: 31395064
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA CCAL promotes gastric cancer cell proliferation and migration in a Myc dependent way.
Shan Y; Kong W; Zhu A; Yu P; Xie Q; Zheng S; Jin H
Pharmazie; 2018 Jan; 73(1):42-48. PubMed ID: 29441950
[TBL] [Abstract][Full Text] [Related]
20. RSK4 knockdown promotes proliferation, migration and metastasis of human breast adenocarcinoma cells.
Zhu J; Li QY; Liu JL; Wei W; Yang HW; Tang W
Oncol Rep; 2015 Dec; 34(6):3156-62. PubMed ID: 26397146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
